| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/10/2011 | US20110059465 Screening assays for agents that alter inhibitor of apoptosis (iap) protein regulation of caspase activity |
| 03/10/2011 | US20110059464 Biomarker Panel For Prediction Of Recurrent Colorectal Cancer |
| 03/10/2011 | US20110059463 Serine and Threonine Phosphorylation Sites |
| 03/10/2011 | US20110059462 Automated particulate concentration system |
| 03/10/2011 | US20110059460 Infection Mediated Foam Dissolution Rate Measurement |
| 03/10/2011 | US20110059456 System for the Cell-Specific and Development-Specific Selection of Differentiating Embryonic Stem Cells, Adult Stem Cells and Embryonic Germline Cells |
| 03/10/2011 | US20110059455 Methods and compositions for direct chemical lysis |
| 03/10/2011 | US20110059452 Methods of screening for gastric cancer |
| 03/10/2011 | US20110059446 Method for determining methylation at cytosine residues |
| 03/10/2011 | US20110059445 Mucosal gene signatures |
| 03/10/2011 | US20110059443 Fluorescent gfp variant displaying highly increased fluorescence intensity without a spectral shift |
| 03/10/2011 | US20110059441 Methof of producing bioactive paper |
| 03/10/2011 | US20110059436 Methods for sequence determination |
| 03/10/2011 | US20110059434 P13k pathway mutations in cancer |
| 03/10/2011 | US20110059432 Method for providing dna fragments derived from a remote sample |
| 03/10/2011 | US20110059430 Cross-spot |
| 03/10/2011 | US20110059134 Prevention of recurrent viral disease |
| 03/10/2011 | US20110059128 Vaccine composition for vaccinating dogs against canine infectious respiratory disease (cird) |
| 03/10/2011 | US20110059105 Tie complex binding proteins |
| 03/10/2011 | US20110059103 Future cardiac event biomarkers |
| 03/10/2011 | US20110059097 MFAP4 as a Marker For Regulatory Cells and Anti-Cancer Cells |
| 03/10/2011 | US20110059092 Antibodies specific of the beta-amyloid peptides and their uses as diagnostic agents or drugs |
| 03/10/2011 | US20110059091 Inhibitors of oncogenic isoforms and uses thereof |
| 03/10/2011 | US20110059089 Protein Markers for Cardiovascular Events |
| 03/10/2011 | US20110059088 Protein involved in ovarian cancer |
| 03/10/2011 | US20110059086 Espfu nucleic acids and proteins and uses thereof |
| 03/10/2011 | US20110059074 Knowledge-Based Proliferation Signatures and Methods of Use |
| 03/10/2011 | US20110059070 Combination therapy for tumoral desease treatment |
| 03/10/2011 | US20110059069 Gapr-1 Methods |
| 03/10/2011 | US20110059066 PAKs as Modifiers of the CHK Pathway and Methods of Use |
| 03/10/2011 | US20110059065 Function and regulation of adamts-1 |
| 03/10/2011 | US20110059064 Vm23 and Vm24, two scorpion peptides that block human T-lymphocyte potassium channels (sub-type Kv1.3) w/High Selectivity and Decrease the in vivo DTH-responses in Rats |
| 03/10/2011 | US20110059055 Treating myelin diseases with optimized cell preparations |
| 03/10/2011 | US20110059051 Molecular Control of Brown Fat Differentiation and Engergy Expenditure |
| 03/10/2011 | US20110059015 Vaccine |
| 03/10/2011 | US20110059012 Identification of cd8+ t cells that are cd161hi and/or il18r (alpha) hi and have rapid drug efflux capacity |
| 03/10/2011 | US20110059011 Diagnosis and treatment of diseased and damaged tissue |
| 03/10/2011 | US20110058985 Analysis device and an analysis apparatus using the analysis device |
| 03/10/2011 | US20110058172 Methods of identifying analytes and using encoded particles |
| 03/10/2011 | US20110056854 Method For Preparing A Lubricating Film, Solid Support Thus Obtained And Preparation Kit |
| 03/10/2011 | US20110056848 Electrochemical test sensor |
| 03/10/2011 | DE112008003435T5 Wegwerfbarer Oberflächenplasmonenresonanzbiosensor und System zu dessen Verwendung Disposable Oberflächenplasmonenresonanzbiosensor and system for using it |
| 03/10/2011 | DE102010035908A1 Einrichtung und Verfahren zur automatischen Erfassung der dynamischen Prozesse von Zellen von Zellproben Apparatus and method for automatically detecting the dynamic processes of cells from cell samples |
| 03/10/2011 | DE102009041885A1 Separation von Mesenchymalen Stammzellen Mesenchymal stem cells separation of |
| 03/10/2011 | DE102009039956A1 Mikrofluidisches System und Verfahren zu dessen Herstellung The microfluidic system and method for its production |
| 03/10/2011 | DE102009039869A1 Gel carrier for implementing comet assay with automation possibilities in robot-based analysis process for the realization of a high throughput method, comprises a carrier plate, whose top side has a support surface for applying the gel |
| 03/10/2011 | DE102009038520A1 Verfahren und Vorrichtung zur Zellprobendiagnostik Method and device for cell samples diagnostics |
| 03/10/2011 | CA2810119A1 Clec14a inhibitors |
| 03/10/2011 | CA2780713A1 Monoclonal antibodies against gonadotropin-releasing hormone receptor |
| 03/10/2011 | CA2772980A1 Neuroprotective ganglioside compositions for use in treating or diagnosing huntington's disease |
| 03/10/2011 | CA2772931A1 Compositions and methods for treatment of neuropathic pain |
| 03/10/2011 | CA2772744A1 In-borehole gas monitor apparatus and method comprising a voc concentration analyser and a voc collector |
| 03/10/2011 | CA2772743A1 Methods, system and device to identify a type of test strip |
| 03/10/2011 | CA2772663A1 Tracking the probability for imminent hypoglycemia in diabetes from self-monitoring blood glucose (smbg) data |
| 03/10/2011 | CA2772643A1 Methods and compositions for detection of lethal cell and uses thereof |
| 03/10/2011 | CA2772623A1 Method for categorizing circulating tumor cells |
| 03/10/2011 | CA2772621A1 Methods and compositions for direct chemical lysis |
| 03/10/2011 | CA2772606A1 Reversible current gel electrophoresis device for separating biological macromolecules |
| 03/10/2011 | CA2772032A1 Antibodies to disulfated heparin disaccharide in the diagnosis of neuropathy |
| 03/10/2011 | CA2771369A1 Determining sensitivity of cells to b-raf inhibitor treatment by detecting kras mutation and rtk expression levels |
| 03/10/2011 | CA2770243A1 Es-ms of glycopeptides for analysis of glycosylation |
| 03/09/2011 | EP2293267A1 Gas detector with visual compliance verification |
| 03/09/2011 | EP2293079A2 Use of precursors of enkephalins and/or their fragments in medical diagnostics |
| 03/09/2011 | EP2293078A2 Method for diagnosis of a bacterial infection |
| 03/09/2011 | EP2293077A2 Methods for detecting coronary artery disease |
| 03/09/2011 | EP2293076A2 Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease |
| 03/09/2011 | EP2293075A2 Method for diagnosing neuro-degenerative disease |
| 03/09/2011 | EP2293074A2 Method for diagnosing neuro-degenerative disease |
| 03/09/2011 | EP2293073A2 Method for diagnosing neuro-degenerative disease |
| 03/09/2011 | EP2293072A1 Use of cathepsin H |
| 03/09/2011 | EP2293071A1 Biomarker for colorectal cancer |
| 03/09/2011 | EP2293070A1 Means and methods for ovarian cancer prognosis |
| 03/09/2011 | EP2293069A2 Methods and compositions for the detection of cervical disease |
| 03/09/2011 | EP2293068A1 Flow sensing for determination of assay results |
| 03/09/2011 | EP2293067A2 T1R hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 03/09/2011 | EP2293066A1 Two-dimensional spectral imaging system |
| 03/09/2011 | EP2293065A2 Methods and compositions for diagnosing hepatocellular carcinoma |
| 03/09/2011 | EP2293064A1 Lipophilic dye-based FRET assays for clostridial toxin activity |
| 03/09/2011 | EP2293063A1 Method of screening candidate compounds for susceptibility to biliary excretion |
| 03/09/2011 | EP2293062A1 Blood analyzer, blood analysis method, hemolytic agent and staining agent |
| 03/09/2011 | EP2293061A1 Method for analysing a biodegraded oil by quantifying the associated saturated hydrocarbons |
| 03/09/2011 | EP2293060A2 Gas sensor |
| 03/09/2011 | EP2293059A2 Profiles of volatile hydrocarbon compounds, markers of degradation/ageing of cellulosic material and disease markers |
| 03/09/2011 | EP2293056A2 A method for analysing a metabolic pathway |
| 03/09/2011 | EP2293029A1 Optical system and method for detection of liquid level in a vessel |
| 03/09/2011 | EP2293028A1 Optical volume sensor |
| 03/09/2011 | EP2293009A1 Residual torsion measuring apparatus |
| 03/09/2011 | EP2292802A2 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| 03/09/2011 | EP2292798A1 Rna in situ hybridization |
| 03/09/2011 | EP2292795A2 Differential enzymatic fragmatation |
| 03/09/2011 | EP2292786A2 Diagnosing and monitoring cardiac transplant rejection based on marker expression levels |
| 03/09/2011 | EP2292785A1 Multi-analyte test strip with shared counter/reference electrode and inline electrode configuration |
| 03/09/2011 | EP2292763A1 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 03/09/2011 | EP2292762A2 VMP-like sequences of pathogenic Borrelia species and strains |
| 03/09/2011 | EP2292760A2 Mammalian cytokines, receptors, related reagents and methods |
| 03/09/2011 | EP2292738A1 Double-transfected cell line useful for the identification of transport inhibitors |
| 03/09/2011 | EP2292732A1 Inhibition assay method and device for detection of antibiotics |
| 03/09/2011 | EP2292710A1 Laminated microfluidic structures and method for making |
| 03/09/2011 | EP2292671A1 Membranes composed of polymers containing heterocyclic nitrogens |
| 03/09/2011 | EP2292666A2 Neoplasm specific antibodies and uses thereof |